Related Experiment Video
Updated: May 22, 2026

Intravitreal Injection and Quantitation of Infection Parameters in a Mouse Model of Bacterial Endophthalmitis
Published on: February 6, 2021
Endogenous aspergillus endophthalmitis after kidney transplantation
Huan-Huan Cheng1, Yong Ding, Min Wu
1Department of Ophthalmology, the First Affiliated Hospital of Jinan University, Guangzhou 510630, Guangdong Province, China.
Endogenous aspergillus endophthalmitis (EAE) after kidney transplant requires prompt diagnosis and treatment. This case highlights successful management using vitrectomy and novel antifungal therapies, offering hope for similar complex cases.
Area of Science:
- Ophthalmology
- Nephrology
- Infectious Diseases
Background:
- Endogenous aspergillus endophthalmitis (EAE) is a rare but serious complication following kidney transplantation.
- Traditional treatments like amphotericin B pose risks, especially for patients with renal impairment.
Purpose of the Study:
- To report a successful treatment modality for EAE in a kidney transplant recipient.
- To emphasize the importance of early diagnosis and multimodal therapy.
Main Methods:
- Diagnosis involved fundoscopy, B-scan ultrasound, and vitreous culture.
- Treatment included vitrectomy, systemic micafungin and voriconazole, and topical fluconazole and amphotericin B.
Main Results:
- Successful control of EAE was achieved through the combined therapeutic approach.
- The patient tolerated the treatment regimen without significant adverse events.
Conclusions:
- Prompt diagnosis and aggressive management, including vitrectomy and a combination of systemic and topical antifungals, are crucial for successful EAE treatment in kidney transplant patients.
- This case demonstrates a viable alternative treatment strategy for EAE in immunocompromised patients with renal compromise.
Related Concept Videos
Kidney Transplant II: Surgical Procedure
Kidney Transplant I: Introduction
Kidney Transplant III: Nursing Management
Endocarditis I: Introduction
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies. Common...
